Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesRedox Regulation of Gamma-glutamyl Transpeptidase
American Journal of Respiratory Cell and Molecular Biology, 08/18/09
Zhang H et al. – Induction of GGT mRNA subtypes and the involvement of multiple signaling pathways vary depending on cell type and stimuli.
Related Articles
Genoproteomic Mining of Urothelial Cancer Suggests gamma-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy
American Journal of Pathology, 10/12/09
Relevance Score: 40%
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: CCTGcctg and SWOG study N0426
Journal of Clinical Oncology, 10/26/09
Relevance Score: 39%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells
British Journal of Cancer, 12/17/09
DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type
Lung Cancer, 12/17/09
Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma
Chest, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor